PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 6, Pages 1405
Publisher
MDPI AG
Online
2019-03-21
DOI
10.3390/ijms20061405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
- (2019) Janice M. Mehnert et al. BMC CANCER
- Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
- (2018) Nikita Pozdeyev et al. CLINICAL CANCER RESEARCH
- PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma
- (2018) Matthew W. Rosenbaum et al. ENDOCRINE PATHOLOGY
- Immune landscape of papillary thyroid cancer and immunotherapeutic implications
- (2018) Kwon Joong Na et al. ENDOCRINE-RELATED CANCER
- Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells
- (2018) Yu-Tang Chin et al. ENDOCRINE-RELATED CANCER
- Novel targeted therapies and immunotherapy for advanced thyroid cancers
- (2018) George E. Naoum et al. Molecular Cancer
- Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
- (2018) Silvia Ferrari et al. ONCOLOGY REPORTS
- Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancer
- (2018) Marra J. Aghajani et al. SURGERY
- Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis
- (2018) Marra Aghajani et al. THYROID
- In papillary thyroid carcinoma, expression by immunohistochemistry of BRAF V600E, PD-L1, and PD-1 is closely related
- (2018) Yanhua Bai et al. VIRCHOWS ARCHIV
- CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers
- (2018) Chiara Tuccilli et al. International Journal of Endocrinology
- Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions
- (2018) Anne M.-Y. Hsieh et al. Oncotarget
- Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
- (2018) Priyanka C. Iyer et al. Journal for ImmunoTherapy of Cancer
- Dysfunction of natural killer cells mediated by PD-1 and Tim-3 pathway in anaplastic thyroid cancer
- (2018) Ming Yin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
- (2018) Anastasia Constantinidou et al. PHARMACOLOGY & THERAPEUTICS
- Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer
- (2018) Viswanath Gunda et al. INTERNATIONAL JOURNAL OF CANCER
- Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes
- (2018) Kyuryung Kim et al. Cancers
- Comprehensive screening for PD-L1 expression in thyroid cancer
- (2017) Soomin Ahn et al. ENDOCRINE-RELATED CANCER
- Current and future immunotherapies for thyroid cancer
- (2017) Alessandro Antonelli et al. Expert Review of Anticancer Therapy
- CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy
- (2017) Karen Zwaenepoel et al. HISTOPATHOLOGY
- Galectin-3 Performance in Histologic and Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis
- (2017) Pierpaolo Trimboli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer
- (2017) Chiara Tuccilli et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study
- (2017) Ashish V. Chintakuntlawar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Deregulated expression of VHL mRNA variants in papillary thyroid cancer
- (2017) Enke Baldini et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
- (2017) Eleonora Molinaro et al. Nature Reviews Endocrinology
- Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
- (2017) Revathi Kollipara et al. ONCOLOGIST
- Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence
- (2017) Rong-liang Shi et al. THYROID
- American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
- (2017) Bryan R. Haugen et al. THYROID
- Thyroid Imaging Reporting and Data System Score Combined with the New Italian Classification for Thyroid Cytology Improves the Clinical Management of Indeterminate Nodules
- (2017) Salvatore Ulisse et al. International Journal of Endocrinology
- New Insight in a New Entity: NIFTPS and Valuable Role of Ancillary Techniques. The Role of PD-L1
- (2017) Esther Diana Rossi et al. EBioMedicine
- Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
- (2017) Guodong Fu et al. EBioMedicine
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
- (2016) Bryan R. Haugen CANCER
- Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification
- (2016) Tommaso Bizzarro et al. CANCER CYTOPATHOLOGY
- PD-1/PD-L and autoimmunity: A growing relationship
- (2016) Mohammad Reza Zamani et al. CELLULAR IMMUNOLOGY
- Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma
- (2016) Bin Xu et al. ENDOCRINE PATHOLOGY
- Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy
- (2016) Paul Lennon et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Cytological features of “noninvasive follicular thyroid neoplasm with papillary-like nuclear features” and their correlation with tumor histology
- (2016) Francesca Maletta et al. HUMAN PATHOLOGY
- Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
- (2016) Jill J. Bastman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Actions of l -thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells
- (2016) Hung-Yun Lin et al. STEROIDS
- Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
- (2016) Eran Brauner et al. Oncotarget
- Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
- (2016) Subrata Chowdhury et al. Oncotarget
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
- (2016) Kankana Bardhan et al. Frontiers in Immunology
- Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
- (2016) Yuri E. Nikiforov et al. JAMA Oncology
- ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
- (2015) Catarina Tavares et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Thyroid Cancer: Outcome and the Mutation/Expression Profiles of Potential Targets
- (2015) Hao Wu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
- (2015) Ninh M. La-Beck et al. PHARMACOTHERAPY
- PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer
- (2015) J. J. Severson et al. Cancer Immunology Research
- Molecular Targeted Therapies of Aggressive Thyroid Cancer
- (2015) Silvia Martina Ferrari et al. Frontiers in Endocrinology
- The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
- (2015) Emanuela Romano et al. Journal for ImmunoTherapy of Cancer
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
- (2014) Nishant Agrawal et al. CELL
- The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer
- (2014) Brian S Henick et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Dendritic cells in autoimmune disorders and cancer of the thyroid
- (2014) Andrzej Lewinski et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- BRAFV600E in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration
- (2014) Trevor E. Angell et al. THYROID
- A New Aurora in Anaplastic Thyroid Cancer Therapy
- (2014) Enke Baldini et al. International Journal of Endocrinology
- The role of the inflammatory microenvironment in thyroid carcinogenesis
- (2013) Lucas Leite Cunha et al. ENDOCRINE-RELATED CANCER
- Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
- (2013) Mei-Ling Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Revisiting Immune-Based Therapies for Aggressive Follicular Cell–Derived Thyroid Cancers
- (2013) Jena D. French THYROID
- Role of the PD-1 Pathway in the Immune Response
- (2012) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) F. Pacini et al. ANNALS OF ONCOLOGY
- Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation
- (2012) Lucas Leite Cunha et al. ENDOCRINE-RELATED CANCER
- Influence of human immune cells on cancer: studies at the University of Colorado
- (2012) Tullia C. Bruno et al. IMMUNOLOGIC RESEARCH
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- (2012) Robert C. Smallridge et al. THYROID
- Resveratrol and apoptosis
- (2011) Hung-Yun Lin et al. Annals of the New York Academy of Sciences
- Expression and Distribution of S-100, CD83, and Costimulatory Molecules (CD80 and CD86) in Tissues of Thyroid Papillary Carcinoma
- (2011) Wen-Can Xu et al. CANCER INVESTIGATION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Tumor-Associated Lymphocytes and Increased FoxP3+Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid Cancer
- (2010) Jena D. French et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
- (2010) J. D. Shields et al. SCIENCE
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- (2008) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search